650
Participants
Start Date
September 3, 2021
Primary Completion Date
May 31, 2022
Study Completion Date
June 30, 2022
Screening, detection and referral for atrial fibrillation
In-pharmacy cardiovascular risk assessment plus AliveCor KardiaMobile reading
Central Study Sponsor Facility, Washington D.C.
American Pharmacists Association Foundation
OTHER